Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-07-29Clinical Trial Update: Exploring a Breast Cancer Early Screening Model Based on cfDNA
This update reports on a completed clinical trial evaluating a breast cancer early screening model based on circulating cell-free DNA (cfDNA…
-
CLINICAL_TRIALS research · 2025-07-29Clinical Trial Update: 5-strain Probiotic Formulation in HR-positive Breast Cancer Receiving Aromatase Inhibitor to Prevent Bone Loss [Phase 2]
Phase 2 clinical trial evaluating a five-strain probiotic formulation to prevent bone loss in patients with hormone receptor-positive breast…
-
CLINICAL_TRIALS research · 2025-07-29Clinical Trial Update: PHESGO Maintenance After T-DXd Short Induction for HER2+ Unresectable Locally Recurrent or Metastatic Breast Cancer [Phase 2]
Phase 2 trial evaluating PHESGO maintenance after short induction with trastuzumab deruxtecan in HER2-positive unresectable locally recurren…
-
CLINICAL_TRIALS trial_result · 2025-07-29Clinical Trial Update: Study Evaluating Abemaciclib + Aromatase Inhibitors in HR+, HER2- Advanced Breast Cancer Patients (HERMIONE-7) [Phase 2]
The HERMIONE-7 Phase 2 trial evaluating abemaciclib in combination with aromatase inhibitors for HR+, HER2- advanced breast cancer has been …
-
CLINICAL_TRIALS research · 2025-07-29Clinical Trial Update: Efficacy of Auricular Acupuncture Therapy in the Prevention of CIPN in Breast Cancer [NA]
A clinical trial update indicates a study is assessing auricular acupuncture therapy to prevent chemotherapy-induced peripheral neuropathy i…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2025-07-28FDA Approved: KISQALI — Supplemental Application (Novartis Pharmaceuticals Corporation)
The FDA approved a supplemental application for Kisqali (ribociclib) submitted by Novartis Pharmaceuticals Corporation, authorizing an updat…
-
FDA approval · 2025-07-28FDA Approved: KISQALI FEMARA CO-PACK — Supplemental Application (Novartis Pharmaceuticals Corporation)
FDA approved a supplemental application to offer a Kisqali (ribociclib) and letrozole (Femara) co-pack, enabling concurrent dispensing of th…
-
CLINICAL_TRIALS trial_result · 2025-07-28Clinical Trial Update: Effect of Pentoxifylline on Preventing Chemotherapy-induced Toxicities in Patients With Breast Cancer [Phase 2]
A Phase 2 trial evaluated whether pentoxifylline can prevent chemotherapy-induced toxicities in breast cancer patients. The study has comple…
-
CLINICAL_TRIALS trial_result · 2025-07-28Clinical Trial Update: Cryotherapy for the Prevention of Taxane-Induced Sensory Neuropathy of the Hands and Feet in Breast Cancer Patients [NA]
This clinical trial evaluates cryotherapy of the hands and feet to prevent taxane-induced sensory neuropathy in breast cancer patients. The …
-
CLINICAL_TRIALS trial_result · 2025-07-28Clinical Trial Update: Niraparib + Dostarlimab In BRCA Mutated Breast Cancer [Phase 2]
Clinical trial update describes a Phase 2 study at Dana-Farber Cancer Institute evaluating Niraparib plus Dostarlimab in BRCA-mutated breast…
-
CLINICAL_TRIALS trial_result · 2025-07-28Clinical Trial Update: Data Analysis for Drug Repurposing for Effective Alzheimer's Medicines (DREAM)- Anastrozole vs Exemestane/Letrozole
A completed clinical trial data-analysis update investigates repurposing anastrozole and related aromatase inhibitors (exemestane, letrozole…
-
CLINICAL_TRIALS research · 2025-07-28Clinical Trial Update: Study of SYN608 for the Treatment of Advanced or Metastatic Solid Tumors [Phase 1]
An early-phase (Phase 1) study of SYN608 for advanced or metastatic solid tumors is not yet recruiting. The indications include ovarian canc…
-
CLINICAL_TRIALS trial_result · 2025-07-28Clinical Trial Update: Initial CDK 4/6 Inhibitor Plus Endocrine Therapy Versus Initial Chemotherapy in HR Positive, HER2 Negative Unresectable or Metastatic Breast Cancer
This completed clinical trial (NCT06344793) evaluated initial treatment with a CDK4/6 inhibitor plus endocrine therapy versus initial chemot…
-
CLINICAL_TRIALS trial_result · 2025-07-28Clinical Trial Update: Endocrine Treatment Alone for Elderly Patients With Estrogen Receptor Positive Operable Breast Cancer and Low Recurrence Score [Phase 2]
Phase 2 clinical trial evaluating endocrine therapy alone for elderly patients with estrogen receptor-positive operable breast cancer and a …
-
CLINICAL_TRIALS research · 2025-07-28Clinical Trial Update: 5 fr Ultrahypofractionated WBI and SIB for Breast Cancer With Unfavorable Characteristics [NA]
A clinical trial is investigating five-fraction ultrahypofractionated whole-breast irradiation with a simultaneous integrated boost for brea…
-
CLINICAL_TRIALS trial_result · 2025-07-25Clinical Trial Update: Gemcitabine, Trastuzumab, and Pertuzumab in the Treatment of Metastatic HER2-Positive Breast Cancer After Prior Trastuzumab/Pertuzumab, or Pertuzumab Based Therapy [Phase 2]
A Phase 2 study evaluated the combination of gemcitabine, trastuzumab, and pertuzumab in patients with metastatic HER2-positive breast cance…
-
CLINICAL_TRIALS trial_result · 2025-07-25Clinical Trial Update: Retrospective Study of 2nd-line Therapies After CDK4/6i + Hormonal Therapy in HR+/HER2- Advanced Breast Cancer
A retrospective analysis examines second-line therapies used after progression on a CDK4/6 inhibitor plus hormonal therapy in patients with …
-
CLINICAL_TRIALS trial_result · 2025-07-25Clinical Trial Update: Somatic Acupressure for Symptom Cluster Management in Breast Cancer Survivors [NA]
A clinical trial evaluating somatic acupressure to manage symptom clusters in breast cancer survivors has completed.
-
CLINICAL_TRIALS research · 2025-07-25Clinical Trial Update: A Phase Ib Safety lead-in, Followed by Phase II Trial of ADG106 in Combination With Neoadjuvant Chemotherapy in HER2 Negative Breast Cancer [Phase 1, Phase 2]
A Phase Ib safety lead-in followed by a Phase II trial evaluating ADG106 in combination with neoadjuvant chemotherapy for HER2-negative brea…
-
CLINICAL_TRIALS research · 2025-07-25Clinical Trial Update: Using a Blood Test to Monitor Metastatic Breast Cancer Treatment
A clinical trial is evaluating a blood-based test to monitor treatment response in metastatic breast cancer and is currently recruiting.
-
CLINICAL_TRIALS research · 2025-07-25Clinical Trial Update: Lenvatinib+Letrozole Versus Fulvestrant in Metastatic ER+/HER2- Breast Cancer, Post Progression on Al + CDK4/6 Inhibitor [Phase 2]
Phase 2 trial evaluating lenvatinib plus letrozole versus fulvestrant in metastatic ER+/HER2- breast cancer after progression on an aromatas…
-
CLINICAL_TRIALS research · 2025-07-25Clinical Trial Update: Web-based Pain Coping Skills Training for Breast Cancer Survivors With AI-Associated Arthralgia [Phase 3]
Phase 3 trial evaluating a web-based Pain Coping Skills Training program for breast cancer survivors with aromatase inhibitor-associated art…
-
CLINICAL_TRIALS research · 2025-07-25Clinical Trial Update: Early Point-of-Service Social and Behavioral Determinants of Health (SBDOH) Screening and Enhanced Navigation on Care Delivery for Patients With Breast Cancer [NA]
This clinical trial update describes a study on early screening for social determinants of health and enhanced navigation to improve care de…
-
CLINICAL_TRIALS research · 2025-07-25Clinical Trial Update: Prospective Randomized Study of Accelerated Radiation Therapy (PRART) [Phase 3]
Phase 3 prospective randomized trial of accelerated radiation therapy for breast cancer is currently active but not recruiting. The entry no…
-
CLINICAL_TRIALS research · 2025-07-25Clinical Trial Update: Minimal Invasive Breast Cancer Excision Using Vacuum Assisted Biopsy Under Ultrasound Guidance [NA]
A clinical trial assessing minimally invasive excision of breast cancer using vacuum-assisted biopsy under ultrasound guidance; the study is…